| Part I Literature Review and StudyWe studied the knowledge of Modern Medicine and Traditional Chinese Medicine(TCM) to Primary Liver cancer Then We discussed the basic and significance of the research. Part II Clinical StudyObjective:To obsever the therapeutic efficacy of Chuankezhi Injection in treating medium or late stage Primary Liver cancer.,Methods:54patients with stage II—III liver cancer were divided randomly into two groups. In Group A(as a treated group),34 patients were treated with Chuankezhi Injection alone.In Group B(as a control group), 20 patients were Huachansu Injection alone.The therapeutic efficancy of the two groups were evaluated after one course of treatment.Results:The Group A had a better effect in the remission of symptoms such as fatigue, anorexia than. Group B (P<0. 05 or P<0. 01) there was no significant difference between Group A and Group B in the remission of symptoms such as pyrexia, ache in liver, meteorism (P>0. 05) . The complete and partial remission rate of Group A was lower than that of Group B, But no significance in statistics (P>0. 05) , Chuankezhi Injection could increase the percentage of NKC , LBT and CD3~+, CD4~+, CD4~+/CD8~+ in T-lymphocyte subcategory statistically while the percentage of NKC , LBT and CD3~+, CD4~+ , CD47~+/CD8~+ in T-lymphocyte subcategory in Group B was not significant. Chuankezhi Injection could discrease the percentage of CD8~+ in T-lymphocyte subcategory ststistically while the percentage of CD8~+ in T-lymphocyte subcategory in Group B was not significant. Group A had a better effect of raising the quality of life and weight than Group B (P<0. 05) ,The Chuankezhi Injection had no severe adverse reaction. Conclusion: The Chuankezhi Injection could alleviate symptoms, improve the... |
PDF Full Text Request